Kohnert K D, Odselius R, Fält K, Ziegler B, Ziegler M, Falkmer S
Diabetes Res. 1987 May;5(1):1-11.
Non-specific activation of the immune system by complete Freund's adjuvant (CFA) in combination with non-diabetogenic doses of streptozotocin (STZ) was used to study autoimmune reactions against pancreatic islets. Male Lewis RT1a rats received either CFA (0.5 ml/kg) 24 hr prior to the injection of STZ (25 mg/kg), or CFA or STZ alone. The injections of CFA followed by STZ, but not CFA or STZ alone, produced a 69% (p less than 0.01) reduction in pancreatic insulin content associated with necrosis and a decrease of the relative volume density of insulin-immunoreactive cells without affecting other islet cells. Two injections of CFA and STZ induced hyperglycemia. This was associated with a depletion of pancreatic insulin and a significant reduction in the relative volume density of insulin-immunoreactive cells (p less than 0.01) and in the mean islet area (p less than 0.01). On day 20, after treatment with 3 injections of CFA and STZ, the animals developed persistent hyperglycemia. The pancreata in these rats contained less than 12% B-cells, and the insulin content was reduced by 96% (p less than 0.01). The main components of the remaining atrophic islets were glucagon- and somatostatin-immunoreactive cells. No significant lymphocytic infiltration into the islets was detectable, but the exocrine parenchyma exhibited severe inflammatory lesions. Degranulation and vacuolation of B-cells was evident by ultra-structural analysis. The volume densities of insulin containing cells and islet area were not changed after 3 injections of either CFA or STZ alone, although the pancreatic insulin content decreased by 61% (p less than 0.01) and 39% (p less than 0.05), respectively. These treatments did not produce an increase in plasma glucose. The present results demonstrate that CFA in combination with non-diabetogenic doses of the beta cytotoxic agent STZ induces B-cell destruction without significant insulitis. Our observations support the hypothesis that activation of the immune system by CFA allows an anti-B-cell immune reaction to develop following exposure to STZ.
通过将完全弗氏佐剂(CFA)与非致糖尿病剂量的链脲佐菌素(STZ)联合使用来非特异性激活免疫系统,以研究针对胰岛的自身免疫反应。雄性Lewis RT1a大鼠在注射STZ(25mg/kg)前24小时接受CFA(0.5ml/kg),或者单独接受CFA或STZ。先注射CFA再注射STZ,而非单独注射CFA或STZ,会使胰腺胰岛素含量降低69%(p<0.01),伴有坏死,胰岛素免疫反应性细胞的相对体积密度降低,且不影响其他胰岛细胞。两次注射CFA和STZ会导致高血糖。这与胰腺胰岛素耗竭以及胰岛素免疫反应性细胞的相对体积密度显著降低(p<0.01)和平均胰岛面积显著减小(p<0.01)有关。在第20天,用CFA和STZ注射3次进行治疗后,动物出现持续性高血糖。这些大鼠的胰腺中B细胞含量低于12%,胰岛素含量降低了96%(p<0.01)。剩余萎缩胰岛的主要成分是胰高血糖素和生长抑素免疫反应性细胞。未检测到胰岛有明显的淋巴细胞浸润,但外分泌实质出现严重炎症病变。超微结构分析显示B细胞有脱颗粒和空泡化现象。单独注射3次CFA或STZ后,含胰岛素细胞的体积密度和胰岛面积未发生变化,尽管胰腺胰岛素含量分别降低了61%(p<0.01)和39%(p<0.05)。这些处理未导致血糖升高。目前的结果表明,CFA与非致糖尿病剂量的β细胞毒性剂STZ联合使用可诱导B细胞破坏而无明显胰岛炎。我们的观察结果支持这样的假说,即CFA激活免疫系统后,在接触STZ时会引发抗B细胞免疫反应。